IP Library › Granted Patent US 8,772,333
Granted Patent B2
US 8,772,333 · App. 13/520,736 · Granted Jul 8, 2014

Fumigillol type compounds and methods of making and using same

Inventor: James E. Vath (Lynnfield, MA)
Assignee: Zafgen, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,772,333
App. No.
13/520,736
Granted
Jul 8, 2014
Kind
B2
Abstract

The disclosure provides a fumagillol type compound and their use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of using, e.g. in the treatment of obesity are provided.

Claims (7)

1. A method of treating and/or controlling obesity, comprising administering to a patient in need thereof an effective amount of the compound represented by

or pharmaceutically acceptable salts or stereoisomers thereof.

2. A method of inducing weight loss in a patient in need thereof, comprising administering to said patient an effective amount of the compound represented by

or pharmaceutically acceptable salts or stereoisomers thereof.

3. The method of claim 1 , wherein the patient is a human.

4. The method of claim 1 , wherein the patient has a body mass index greater than or equal to about 25 kg/m 2 before the administration.

5. The method of claim 1 , wherein the compound is administered orally, intravenously, or subcutaneously.

Continuity (2)
Provisional Application 61293318 · Jan 8, 2010
Related Publication 20130018095A1 · Jan 17, 2013